Octamoxin

DB09249

small molecule withdrawn

Deskripsi

Octamoxin, also known as 2-octylhydrazine, is both an irreversible and nonselective monoamine oxidase enzyme inhibitor (MAOI) of the hydrazine chemical class. This drug was used in the past as an antidepressant agent in the 1960s, however, has since been discontinued.

Struktur Molekul 2D

Berat 144.262
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1322 Data
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Octamoxin.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Octamoxin.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Octamoxin.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Octamoxin.
Magnesium sulfate The therapeutic efficacy of Octamoxin can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Octamoxin may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Octamoxin.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Octamoxin.
Orphenadrine Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Octamoxin.
Pramipexole Octamoxin may increase the sedative activities of Pramipexole.
Ropinirole Octamoxin may increase the sedative activities of Ropinirole.
Rotigotine Octamoxin may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Octamoxin.
Sodium oxybate Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Thalidomide Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Octamoxin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Desmopressin The risk or severity of hypertension can be increased when Desmopressin is combined with Octamoxin.
Cyclosporine The risk or severity of hypertension can be increased when Cyclosporine is combined with Octamoxin.
Icosapent The risk or severity of hypertension can be increased when Icosapent is combined with Octamoxin.
Mesalazine The risk or severity of hypertension can be increased when Mesalazine is combined with Octamoxin.
Indomethacin The risk or severity of hypertension can be increased when Indomethacin is combined with Octamoxin.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Octamoxin.
Nabumetone The risk or severity of hypertension can be increased when Nabumetone is combined with Octamoxin.
Ketorolac The risk or severity of hypertension can be increased when Ketorolac is combined with Octamoxin.
Tenoxicam The risk or severity of hypertension can be increased when Tenoxicam is combined with Octamoxin.
Celecoxib The risk or severity of hypertension can be increased when Celecoxib is combined with Octamoxin.
Tolmetin The risk or severity of hypertension can be increased when Tolmetin is combined with Octamoxin.
Rofecoxib The risk or severity of hypertension can be increased when Rofecoxib is combined with Octamoxin.
Piroxicam The risk or severity of hypertension can be increased when Piroxicam is combined with Octamoxin.
Fenoprofen The risk or severity of hypertension can be increased when Fenoprofen is combined with Octamoxin.
Valdecoxib The risk or severity of hypertension can be increased when Valdecoxib is combined with Octamoxin.
Diclofenac The risk or severity of hypertension can be increased when Diclofenac is combined with Octamoxin.
Sulindac The risk or severity of hypertension can be increased when Sulindac is combined with Octamoxin.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Octamoxin.
Flurbiprofen The risk or severity of hypertension can be increased when Flurbiprofen is combined with Octamoxin.
Etodolac The risk or severity of hypertension can be increased when Etodolac is combined with Octamoxin.
Mefenamic acid The risk or severity of hypertension can be increased when Mefenamic acid is combined with Octamoxin.
Naproxen The risk or severity of hypertension can be increased when Naproxen is combined with Octamoxin.
Sulfasalazine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Octamoxin.
Phenylbutazone The risk or severity of hypertension can be increased when Phenylbutazone is combined with Octamoxin.
Meloxicam The risk or severity of hypertension can be increased when Meloxicam is combined with Octamoxin.
Carprofen The risk or severity of hypertension can be increased when Carprofen is combined with Octamoxin.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Octamoxin.
Diflunisal The risk or severity of hypertension can be increased when Diflunisal is combined with Octamoxin.
Salicylic acid The risk or severity of hypertension can be increased when Salicylic acid is combined with Octamoxin.
Meclofenamic acid The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Octamoxin.
Dopamine The risk or severity of hypertension can be increased when Dopamine is combined with Octamoxin.
Oxaprozin The risk or severity of hypertension can be increased when Oxaprozin is combined with Octamoxin.
Ketoprofen The risk or severity of hypertension can be increased when Ketoprofen is combined with Octamoxin.
Balsalazide The risk or severity of hypertension can be increased when Balsalazide is combined with Octamoxin.
Ibuprofen The risk or severity of hypertension can be increased when Ibuprofen is combined with Octamoxin.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Octamoxin.
Propafenone The risk or severity of hypertension can be increased when Propafenone is combined with Octamoxin.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Octamoxin.
Lumiracoxib The risk or severity of hypertension can be increased when Lumiracoxib is combined with Octamoxin.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Octamoxin.
Magnesium salicylate The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Octamoxin.
Salsalate The risk or severity of hypertension can be increased when Salsalate is combined with Octamoxin.
Choline magnesium trisalicylate The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Octamoxin.
Antrafenine The risk or severity of hypertension can be increased when Antrafenine is combined with Octamoxin.
Aminophenazone The risk or severity of hypertension can be increased when Aminophenazone is combined with Octamoxin.
Antipyrine The risk or severity of hypertension can be increased when Antipyrine is combined with Octamoxin.
Tiaprofenic acid The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Octamoxin.
Etoricoxib The risk or severity of hypertension can be increased when Etoricoxib is combined with Octamoxin.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Octamoxin.
Taxifolin The risk or severity of hypertension can be increased when Taxifolin is combined with Octamoxin.
Oxyphenbutazone The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Octamoxin.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Octamoxin.
Benoxaprofen The risk or severity of hypertension can be increased when Benoxaprofen is combined with Octamoxin.
Metamizole The risk or severity of hypertension can be increased when Metamizole is combined with Octamoxin.
Zomepirac The risk or severity of hypertension can be increased when Zomepirac is combined with Octamoxin.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Octamoxin.
Cimicoxib The risk or severity of hypertension can be increased when Cimicoxib is combined with Octamoxin.
Amibegron The risk or severity of hypertension can be increased when Amibegron is combined with Octamoxin.
Nylidrin The risk or severity of hypertension can be increased when Nylidrin is combined with Octamoxin.
Solabegron The risk or severity of hypertension can be increased when Solabegron is combined with Octamoxin.
Lornoxicam The risk or severity of hypertension can be increased when Lornoxicam is combined with Octamoxin.
Aceclofenac The risk or severity of hypertension can be increased when Aceclofenac is combined with Octamoxin.
Zaltoprofen The risk or severity of hypertension can be increased when Zaltoprofen is combined with Octamoxin.
Saralasin The risk or severity of hypertension can be increased when Saralasin is combined with Octamoxin.
Azapropazone The risk or severity of hypertension can be increased when Azapropazone is combined with Octamoxin.
Parecoxib The risk or severity of hypertension can be increased when Parecoxib is combined with Octamoxin.
Salicylamide The risk or severity of hypertension can be increased when Salicylamide is combined with Octamoxin.
Tyramine The risk or severity of hypertension can be increased when Tyramine is combined with Octamoxin.
Mirabegron The risk or severity of hypertension can be increased when Mirabegron is combined with Octamoxin.
Adrafinil The risk or severity of hypertension can be increased when Adrafinil is combined with Octamoxin.
Kebuzone The risk or severity of hypertension can be increased when Kebuzone is combined with Octamoxin.
Isoxicam The risk or severity of hypertension can be increased when Isoxicam is combined with Octamoxin.
Indoprofen The risk or severity of hypertension can be increased when Indoprofen is combined with Octamoxin.
Ibuproxam The risk or severity of hypertension can be increased when Ibuproxam is combined with Octamoxin.
Floctafenine The risk or severity of hypertension can be increased when Floctafenine is combined with Octamoxin.
Fenbufen The risk or severity of hypertension can be increased when Fenbufen is combined with Octamoxin.
Etofenamate The risk or severity of hypertension can be increased when Etofenamate is combined with Octamoxin.
Etilefrine The risk or severity of hypertension can be increased when Etilefrine is combined with Octamoxin.
Epirizole The risk or severity of hypertension can be increased when Epirizole is combined with Octamoxin.
Benzydamine The risk or severity of hypertension can be increased when Benzydamine is combined with Octamoxin.

Referensi & Sumber

Artikel (PubMed)

Contoh Produk & Brand

Produk: 0 • International brands: 2
International Brands
  • Nimaol
  • Ximaol

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul